Isracann Biosciences Inc. Strategic Investment
Post# of 4861
(Total Views: 273)
Posted On: 05/21/2020 10:20:04 AM
Isracann Biosciences Inc.
Strategic Investment Newsletter | James Dale Davidson 05/21/2020
A disruptive under-the-radar company has taken the lead in low-priced medical cannabis production that could put it on the road to massive profits.
The company has a number of extraordinary competitive advantages that suggest one should take a closer look at what it has to offer investors.
Analyze the company, speak with management and even visited medical cannabis farms if you are in the area, early investors in Isracann Biosciences Inc. (ISCNF) could profit handsomely, as could all of their partners.
Isracann Biosciences Inc. could produce potential growth of 740% or more, just like its South American counterpart PharmaCielo.
Source: Strategic Investment Newsletter written by James Dale Davidson 5/21/2020
https://wallstreetrebel.com/wsr/native/10_rea...00-00.html
Strategic Investment Newsletter | James Dale Davidson 05/21/2020
A disruptive under-the-radar company has taken the lead in low-priced medical cannabis production that could put it on the road to massive profits.
The company has a number of extraordinary competitive advantages that suggest one should take a closer look at what it has to offer investors.
Analyze the company, speak with management and even visited medical cannabis farms if you are in the area, early investors in Isracann Biosciences Inc. (ISCNF) could profit handsomely, as could all of their partners.
Isracann Biosciences Inc. could produce potential growth of 740% or more, just like its South American counterpart PharmaCielo.
Source: Strategic Investment Newsletter written by James Dale Davidson 5/21/2020
https://wallstreetrebel.com/wsr/native/10_rea...00-00.html
(2)
(0)Scroll down for more posts ▼